PharmaCyte Biotech PMCB Q1 2026 Earnings Narrowing Loss Amid Strategic Pipeline Progress SWKH Q3 2025 Earnings Strong EPS Beat Driven by Investment Gains and Portfolio Performance KGEI Q1 2026 Earnings EPS Misses Expectations Stock Declines 82 OPRA Q1 2026 Earnings EPS Tops Estimates as Opera Delivers Modest Beat LOPE Q1 2026 Earnings EPS Surpasses Estimates Stock Slips Slightly Modiv Industrial Inc Class C MDV Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges